Company: SQFTP
Filing Date: 2025-10-14
Form Type: 424B5
Source: 0001493152-25-018010
Chunk: 16

Company: Presidio Property Trust, Inc.
Filing Date: 2025-10-14
Form: 424B5
Chunk 16
---
 any prospectus supplement or other offering material, as well as any risks described in the documents incorporated by reference into this prospectus supplement and the accompanying prospectus for a description of certain risks that could, among other things, cause our actual results to differ from these forward-looking statements. You should understand that it is not possible to predict or identify all such factors and that this list should not be considered a complete statement of all potential risks and uncertainties. You should also realize that if the assumptions we have made prove inaccurate or if unknown risks or uncertainties materialize, actual results could vary materially from the views and estimates included or incorporated by reference in this prospectus supplement and the accompanying prospectus. Except as required by law, we are under no obligation, and we do not intend, to update any forward-looking statement, whether as result of new information, future events or otherwise.

<div align='center'>USE OF PROCEEDS</div>

We currently intend to use the estimated net proceeds from the sale of our shares in this offering for working capital and other general corporate purposes.

There is no guarantee that we will sell the shares covered by this prospectus supplement and, in the event that we do, there is no guarantee as to the total number of shares that we will sell, nor is there any guarantee as to the amount of net proceeds of this offering to be applied to any one particular proposed use as described above. Our management will have significant discretion and flexibility in applying the net proceeds from the sale of these shares. Pending any use, as described above, we intend to invest the net proceeds in high-quality, short-term, interest-bearing securities. If the maximum number of shares are sold in this offering, we estimate that the net proceeds from the sale of shares of our common stock in this offering will be approximately $1.2 million.

| S-11 |

<div align='center'>PLAN OF DISTRIBUTION</div>

We have entered into the Sales Agreement, dated as of October 14, 2025, with The Benchmark Company, LLC as sales agent under which we may issue and sell shares of our Series A Common Stock having an aggregate offering price of up to $1,419,265 from time to time through The Benchmark Company, LLC acting as our sales agent.

The Sales Agreement provides that sales of our Series A Common Stock, if any, under this prospectus supplement may be made in sales deemed to be “at-the-market” equity offerings as defined in Rule 415(a)(4) promulgated under the Securities Act including sales